PD-1 Gene Expression Profiles For Drug Development US Patent Awarded To VGTI Florida Scientists

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--The Vaccine and Gene Institute of Florida (VGTI Florida) announced today that the US Patent and Trademark Office awarded VGTI Florida scientists Dr. Rafick-Pierre Sékaly, PhD and Dr. Elias Haddad, PhD U.S. Patent No. 8,647,822 titled DETERMINING WHETHER A TEST COMPOUND MODULATES PD-1 ACTIVITY IN ACTIVATED IMMUNE CELLS USING GENE EXPRESSION PROFILES.

Help employers find you! Check out all the jobs and post your resume.